NEU 3.50% $14.05 neuren pharmaceuticals limited

Ann: Neuren announces cancer xenograft testing re, page-42

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,255 Posts.
    lightbulb Created with Sketch. 64
    re: Ann: Neuren announces cancer xenograft te... HI ximing- I wish I new the answer buddy. The market does not always react like we expect. Sometime news is not all positive EVEN if the most important parts are positive people will overlook the positives and sell the negatives.....

    I am not a Bio Tech guru so I look at the simple indicators. (cash, US army support, amount of phase II trials ect ect)Persis was never the main company asset but it did/does offer another Iron in the fire.

    I am still holding long term as I am hoping to see a good rerate over the next few months. I was hoping for a better announcement BUT not everything we want comes true. Tomorrow is another day.

    good luck,,,
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.